PDS in the News

Protein Dynamic Solutions appoints Selena Larkin as Chief Commercial Officer

  

Wakefield, MA – July 24, 2018 – Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for biopharmaceutical characterization of therapeutic proteins, announces the appointment of Dr. Selena Larkin to its leadership team. 

 

“We are delighted to welcome Selena to the PDS team”, said Dr. Belinda Pastrana, CEO.  “Her experience promoting innovative technologies across her global biopharmaceutical network and her understanding of, and enthusiasm for, protein chemistry will further speed adoption of PDS’ enabling platforms”. 


Read the entire release here:

https://pharmaceuticals.einnews.com/pr_news/456493837/protein-dynamic-solutions-appoints-selena-larkin-as-chief-commercial-officer

Protein Dynamic Solutions Named to “The Most Valuable Venture-Backed Startups in All 50 States”

  

Wakefield, MA – July 16, 2018 – Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for structural characterization of therapeutic proteins, was recognized by Business Insider for provision of instruments and contract research services to the biopharmaceutical industry.


The listing was researched and compiled by PitchBook and represented in their infographic on the most valuable VC-backed company in each US state.


Read the entire release here: https://www.bizjournals.com/boston/businesswire/press_releases/Massachusetts/2018/07/16/20180716005151


Protein Dynamic Solutions establishes new headquarters and operations in Massachusetts

Wakefield, MA – June 16, 2018 – Protein Dynamic Solutions LLC (PDS), developer of platforms for biopharmaceutical critical quality attribute (CQA) and biosimilar assessment, has recently established a new head office, as well as research and operations, in Wakefield, Massachusetts.


Founded in Puerto Rico by veterans of the biopharmaceutical industry, PDS is a provider of tools for high-throughput developability and comparability (HT-DCA) testing of therapeutic proteins. Their novel, array-based platforms incorporate bench-top laser microscopes and novel high-throughput sample handling and analysis technologies to provide visual and hyper-spectral analyses of biotherapeutics; thus, informing the structures, mechanisms and amino acid residues involved in protein stability, aggregation and change.


“We are very excited to establish a presence in the Boston biotechnology hub,” said Belinda Pastrana, Founder and CEO. “We have worked in, and supported, global biopharma companies for many years and it’s invigorating to now have a home at the source of many of the innovations in our industry. We are delighted to be geographically co-located with our key clients and partners and to play an intimate role in their go-forward pipeline strategies.”


Read the entire release here:

https://www.biopharmadive.com/press-release/20180619-protein-dynamic-solutions-establishes-new-headquarters-and-operations-in-ma/

PDS' CEO delivers presentation at 2018 PITTCON William Wright Award

February 2018

Dr. Belinda Pastrana, the CEO of Protein Dynamic Solutions, was invited as a speaker at the The Coblentz Society - Williams Wright Award at this year's PITTCON meeting, recognizing and honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy.

About the award: http://www.coblentz.org/awards/the-williams-wright-award

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase II TECP Supplemental award

August 2017

PDS was awarded a continuation of a previously funded SBIR Phase II Award with grant of additional TECP supplemental funding in support of Proof of Concept analysis in partnership with Catalent Biologics.

About Catalent Biologics: https://biologics.catalent.com/index.php

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase II Award

September 2016

Continuing in its strong history for awarding of industry grants, PDS was awarded the SBIR Phase II Award.

Award Details: https://www.sbir.gov/sbc/protein-dynamic-solutions-inc

Protein Dynamic Solutions LLC is selected to participate in NIH I-Corps workshop

March 2016

PDS was honored to be one of four companies selected for the NIH I-Corps workshop - a program that seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society.

As a participant, PDS leaders received instruction and mentoring from industry experts in order to accelerate the translation of its breakthrough technologies. Scientific rigor, societal impact and business models were reviewed and vetted by over 185 professionals from the biopharmaceutical industry and government regulatory authorities.

Read about the program and interview with PDS' CEO Belinda Pastrana: http://www.biotech-now.org/business-and-investments/business-of-biotech/2015/06/bio-innovation-zone-company-snapshots-protein-dynamic-solutions

Protein Dynamic Solutions LLC is accepted into the Life Sciences Entrepreneurs Acceleration Program

December 2015

The law firm of McDermott, Will and Emery welcomed Protein Dynamic Solutions, LLC into its prestigious Life Sciences Entrepreneurs Acceleration Program (LEAP).

The program works with entrepreneurs to provide sophisticated advice on a broad range of legal and business issues and accelerate the progression of companies to meet strategic objectives.

Candidates for LEAP are sponsored by a McDermott partner and evaluated on the quality of their business plan, the ability of the company to meet well-defined milestones, current levels of investment (or the likelihood of obtaining venture-backed financing), and clearance of a business and legal conflict evaluation.

Program overview: http://files.mwe.com/files/Uploads/Documents/LEAP/LEAP_FAQ.pdf


Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase I Award

January 2015

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase I Award

Award Details: https://www.sbir.gov/sbc/protein-dynamic-solutions-inc

Protein Dynamic Solutions awarded Puerto Rico Science & Technology Trust Collaborative Agreement

January 2013